Funding highlight reel
(an Air Street investment), the personalised nutrition company known for its large-scale microbiome clinical studies, raised
a $20M Series B led by Ahren. If you’re based in the US, you can order the product today at www.joinzoe.com
, the AI-first clinical stage drug development company, raised
a $225M Series D led by SoftBank Vision Fund 2. The Fund is also providing an additional $300M equity commitment that can be drawn at the Company’s discretion. This funding comes on the back of two active clinical trials for drugs designed by Exscientia - a world first.
, the adeno-associated viral vector design company focused on gene therapy, raised
a $100M Series A led by a16z.
, the Swedish electric and autonomous freight mobility company, raised
a $110M Series B from Temasek, Soros Fund management and others.
, a new AI safety-focused research company formed by alums of OpenAI, raised
a $124M maiden financing round.
, the Berlin-based telemedicine company, raised
a $90M from by Leaps by Bayer.
, an AI-first software company built for insurers, raised
a $220m Series D led by Advent International at a unicorn valuation. The product offers decision automation across underwriting, subrogation, and compliance. It serves 100 customers in 25 countries.
, the analog chip company, raised
a $70M Series C led by BlackRock and Hewlett Packard Enterprise.
, the cybersecurity company focused on human mistakes, raised
a $65M Series C led by March Capital.
, the French autonomous shuttle company, raised
a €55M Series B led by Searchlight Capital Partners. The company has deployed 180 vehicles in 30 countries to date.
, a cybersecurity company that lets customers run machine-based attack simulations on their networks to discover vulnerabilities, raised
a $45M Series C led by One Peak Partners.
, a location data analytics company, raised
a $50M Series B led by angels Josh Buckley, Todd Goldberg and Rahul Vohra.
the financial crime prevention company, extended
its Series C to $70M with new investment from Goldman Sachs.
, a software company that helps researchers navigate biomedical research, raised
a $17M Series A led by Index.
, a company that automates welding in manufacturing plants, raised
a $56M Series B led by Addition.
, a computer vision control system for logistics robots, raised
a $33M Series B led by McRock capital.
, an insurance focused startup applying NLP and computer vision to claims automation, raised
a $11M Series A led by Octopus Ventures.
, an MLOps company, raised
a $21M Series A led by Bessemer.
, a video compression company, raised
a $6.3M round led by Octopus Ventures.
Lyft Level 5
, the self-driving division of Lyft, announced its intention to be acquired
by Woven Planet (a Toyota holding company focused on autonomous driving) for $550M. Of this, $200M is upfront and $35M is paid over five years. For Lyft, this also means a saving of $100M in net operating expenses from reduced R&D. To dive deeper into the consolidation of AVs, have a read of this post
, the AI-first supply chain software company for retail, manufacturing and logistics customers, was acquired
by Panasonic for up to $8.5B.
, the company that engineers novel organisms to produce useful materials and substances, merged with a SPAC to value the public company at $17.5B post-money. You can find the investor deck here
, makers of waveguide technology for use in augmented reality headsets, was acquired
by Snap for $500M.
, a precision medicine liquid biopsy company, was acquired
by NeoGenomics for $390M. This follows NeoGenomics’ $25M investment in May 2020. Inivata was formed around technology developed at Nitzan Rosenfeld’s
group based in the Cancer Research UK Cambridge Institute (where I did my PhD).
, a software-based inference accelerator, was acquired
by Nano Dimension, a 3D printer manufacturer working on additively manufactured electronics. The deal is worth $70M.
, a 3D mapping company using crowdsourced data, was acquired
Nathan Benaich, 13 June 2021
Air Street Capital is a venture capital firm investing in AI-first technology and life science companies. We’re an experienced team of investors and founders based in Europe and the US with a shared passion for working with entrepreneurs from the very beginning of their company-building journey.